Imunoterapi Dokter Terbaik di Istambul - TOP-16 dokter

• Mengkhususkan diri dalam imunoterapi kanker dan terapi terarah.
• Terlatih dalam imunoonkologi di Mount Vernon Cancer Center, London, Inggris.
• Tersertifikasi oleh European Society of Medical Oncology (ESMO).
• Anggota ESMO dan European School of Oncology.
• Berpraktik di Amerika Serikat dan Turki.

• Spesialis dalam imunoterapi kanker menggunakan terapi target.
• Telah menjalani pelatihan di Turki dan di Komando NATO KFOR.
• Anggota Asosiasi Onkologi Medis Turki.
• Lebih dari 40 publikasi dalam penelitian kanker, dengan fokus pada imunoterapi.
• Profesor di Fakultas Kedokteran Universitas Okan Istanbul.

Dr. Sinan Karaaslan — Dokter Onkologi Medis di Anadolu Medical Center (sejak 2014). Ia menangani kanker payudara, kolorektal, dan genitourinari; dalam onkologi medis sejak 2003. Anggota dari Asosiasi Medis Turki, Masyarakat Onkologi Medis Turki, dan Masyarakat Kanker Paru-Paru Turki.

Mengapa pasien memilih dan mempercayai Dr. Karaaslan:

• Menangani kasus kanker payudara, kolorektal, dan genitourinari yang kompleks — menerapkan terapi sistemik modern yang disesuaikan dengan tipe dan stadium tumor.
• Anggota dari Asosiasi Medis Turki, Masyarakat Onkologi Medis Turki, dan Masyarakat Kanker Paru-Paru Turki.
• Penulis dari banyak artikel yang telah ditinjau sejawat dan materi edukasi pasien tentang kemoterapi dan imunoterapi.
• Bekerja di pusat dengan status ESMO Designated Centre dan akreditasi JCI, dalam kolaborasi strategis dengan Johns Hopkins Medicine International — salah satu institusi medis terkemuka di AS. Bagi pasien, ini berarti perawatan yang sesuai dengan protokol AS dan penggunaan peralatan canggih.

Dia telah bekerja sebagai dokter spesialis penyakit dalam dan spesialis onkologi medis di Pusat Medis Anadolu sejak tahun 2021.
 

Dr. Serkan Keskin adalah seorang ahli onkologi yang sangat berpengalaman, dengan spesialisasi dalam kemoterapi. Ia memiliki banyak prestasi di bidangnya, termasuk meraih peringkat pertama dalam Ujian Kecakapan Onkologi Medis di Turki pada tahun 2012. Ia adalah anggota aktif dari berbagai masyarakat onkologi bergengsi, dan memiliki profil akademis yang kuat dengan 42 artikel yang diterbitkan dalam jurnal internasional.

• Menggunakan inhibitor pos pemeriksaan dan terapi CAR T-sel untuk imunoterapi.
• Dilatih di Turki dan Amerika Serikat, termasuk di MD Anderson Cancer Center.
• Anggota American Society of Clinical Oncology.
• Spesialis dalam imunoterapi untuk berbagai jenis kanker termasuk paru-paru dan payudara.
• Menyelesaikan program fellowship di Institut Kanker Universitas Hacettepe.

• Menggunakan inhibitor titik pemeriksaan dan antibodi monoklonal untuk pengobatan imunoterapi.
• Telah dilatih dan berpraktik secara internasional, termasuk di Turki.
• Merupakan anggota dari European Society for Medical Oncology.
• Telah dianugerahi Penghargaan Penelitian Onkologi oleh Asosiasi Onkologi Medis Turki.
• Telah menulis lebih dari 20 makalah tentang onkologi medis.

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

Professor of Oncology and Hematology

Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.

Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.

Saat Ini
Rumah Sakit Istanbul Florence Nightingale
Onkologi Medis

2022-2024
Rumah Sakit Memorial Şişli
Spesialis Onkologi Medis

2021-2022
Institut Jules Bordet
Beasiswa Penelitian Klinis

2020-2022
Rumah Sakit Pendidikan dan Penelitian Universitas Marmara Pendik
Spesialis Onkologi Medis

2019-2019
Institut Jules Bordet
Beasiswa Penelitian Klinis

2016-2019
Fakultas Kedokteran Universitas Marmara, Departemen Onkologi Medis
Fellowship Onkologi Medis

2014-2016
Rumah Sakit Umum Golbasi
Spesialis Penyakit Dalam

2013-2014
MD Anderson Cancer Center
Observership

2013
Rumah Sakit Bellvitge, Barcelona, Spanyol
Observership

2009 -2014
Fakultas Kedokteran Universitas Hacettepe
Residensi Penyakit Dalam

Education and Expertise

Selcuk University Meram Faculty of Medicine - Medical Education

Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization

Experience

Malatya State Hospital Internal Diseases Clinic

Ankara Oncology Hospital Medical Oncology Clinic

Erzurum Regional Training and Research Hospital Medical Oncology Clinic


AREAS OF INTEREST

Lung cancer

esophageal cancer

Gastric cancer

breast cancer

Gastrointestinal surgery

https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr 

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.